The Leukemia Research Foundation exclusively funds New Investigators - individuals beginning to establish their own laboratories that are no longer under the tutelage of a senior scientist mentor. It is difficult for them to get the level of funding they need at this critical point in their careers.
The Leukemia Research Foundation is unique in the level of support it provides to highly promising scientists in this absolutely critical research niche. Providing one year grants of $100,000 to selected New Investigator researchers, allows innovative scientists to act on their ideas, and try new procedures and experiments that will hopefully lead to significant,breakthroughs. The Leukemia Research Foundation funds the research of scientists that are from independent labs, not the labs of pharmaceutical companies.
Researchers funded by the LRF publish their results in an effort to inform the scientific community about their advances. In addition, their initial results are used to obtain grants from larger, multi-year funding sources - thus furthering their research and potential for finding a cure.
Support of the LRF will fuel today’s creative ideas and help launch the careers of scientists who may further our understanding of blood cancers for years to come. Founded in 1946, the LRF has raised more than $72 million in its 71-year history supporting its mission.
Deadlines:
- Friday, February 14, 2025: Letter of intent due by 12pm CT (noon)
- Friday, March 21, 2025: Notification if invited to submit a full application
- Friday, April 25, 2025: Full application due (if invited to submit) by 12pm CT (noon)
- New investigators are considered to be within seven years of their first independent faculty-level position when the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years and are not included in the seven-year guideline.
- Researcher must be in an independent faculty-level position at the time the application is submitted.
- Adjustments for career interruptions can be made. These could include but are not limited to family leave, military service, major illness, or injury. It is the responsibility of the applicant to point out and document such interruptions.
- Applicants are not required to be US citizens. Research projects from outside the US are eligible.
- Applicants with a KO8, K23, R00, or R99 grant are eligible. The total grant amount will not be applied toward the $175K per year threshold on total direct costs.
- DOE, DOD, NSF, R21, or other grants with less than $175K per year in total direct costs are permitted.
- Only one LOI may be submitted from the same applicant.
Not eligible
- Applicants with any active single grant (or multiple grants added together) that total $175K or greater in total direct costs per year are not eligible (as noted above, KO8, K23, R00, R99 grant awards are excluded from this total threshold).
- Fellows are not eligible to apply.
- Applicants with NIH RO1 funding, VA Merit Award, or equivalent.
- Applicants with career development awards from other national foundations (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
- Renewal applications will not be accepted.
- Co-PI's are not permitted.
2015:
Eda Yildirim, Ph.D. – Duke University
Xist long noncoding RNA mediated gene expression and epigenetic stability in hematologic malignancies
2003
Tannishtha Reya, Ph.D.
Regulation of Hematopoietic Stem Cell Self-Renewal by Wnt Signaling